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ABSTRACT 
 
Patients who attend genetic counseling appointments report high anxiety and 
varied satisfaction levels following their appointments. It has been suggested in previous 
literature that some of the increase in anxiety and reduction in satisfaction is caused by 
lack of prior information. Here, I investigated whether providing patients with a glossary 
of genetic terms prior to their counseling appointment improves patient satisfaction and 
reduces anxiety in an oncology genetic counseling appointment. I surveyed 96 patients 
attending their first genetic counseling appointment at Banner MD Anderson Cancer 
Center and analyzed 92 patients for which I had complete data. Patients were randomly 
selected to receive one of two folders, containing either an educational document or an 
educational document and a glossary comprised of ten genetic terms. Each patient was 
given a post-counseling survey at the end of the counseling appointment to assess their 
anxiety and satisfaction levels. I did not observe a statistically significant difference in 
levels of anxiety or satisfaction, but the data are consistent with increased satisfaction for 
patients who received a glossary. Interesting, the data are also consistent with decreased 
anxiety levels for patients who did not receive a glossary. Furthermore, I did observe 
differences in reported satisfaction with patients who had college experience and patients 
that did not have any college experience. 
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INTRODUCTION 
As a field, medical genetics has attracted the attention of the general population; 
however, the complex topics and scientific jargon make it particularly difficult for the 
average person to understand. Due to the increasing use of, and interest in, personalized 
genetics such as 23andMe, Ancestry DNA and patient’s own family histories, individuals 
who can explain genetic testing results (i.e. genetic counselors) have risen in demand. 
Genetic counseling helps people to understand their family’s risks to genetic disorders by 
educating patients about their family history, testing options, and, if needed, prevention, 
resources and types of management of illnesses (Resta et al., 2006). Oncology genetic 
counseling is a subspecialty in the genetic counseling field that focuses on the 
identification and management of inherited cancer risks (Motulsky et al., 1994; Schild, 
1979).  
Prior research has shown that patients’ satisfaction and anxiety levels in a genetic 
counseling appointment are impacted by the uncertainty and lack of education (Motulsky 
et al., 1994). Anecdotal evidence here in Arizona shows that confusion about the 
counseling appointment, including its purpose and goal, can naturally occur since 
educational materials are not consistently given to patients prior to a counseling 
appointment (Phoenix/Tucson Genetic Counselors). Previous studies note that the 
uncertainty and lack of education can be fixed by providing patients with educational 
materials prior to a genetic counseling appointment to allow patients to prepare and to 
know what to expect during their counseling appointment (Motulsky et al., 1994; 
Hallowell et al., 1997).   
Due to the general population’s lack of experience with genetic counseling and 
genetic terminology, anxiety can often be an unintended consequence of a genetic 
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counseling appointment (Motulsky et al., 1994; Chapple et al., 1997). Specifically, 
regarding genetics, patients who hear terminology they have not heard before – such as 
“mutation”, “defect” or “syndrome” – may associate these words with alarming images 
causing them to view themselves as imperfect or flawed in some way. (Chapple et al., 
1997; Motulsky et al., 1994). Hearing words, that have a traditionally negative 
connotation with no context may cause patients to view themselves as defective or sick, 
which can in turn increase levels of anxiety (Chapple et al., 1997; Motulsky et al., 1994; 
Kessler, 1979). Also, studies have shown that increased levels of anxiety during a 
counseling appointment could lead to limited retention of the genetic information 
provided (Motulsky et al., 1994; Childs, 1976; Kessler, 1989). Elevated levels of anxiety 
during a counseling appointment could cause confusion and lead to poor decisions 
(Motulsky et al., 1994; Chapple et al., 1997). Additionally, people who have not taken a 
biology class or reached higher levels of education (e.g. high school) may feel vulnerable 
throughout the counseling appointment due to difficulties communicating with the 
genetic counselors (Chapple et al., 1997). Although genetic counseling caters to patients 
of all educational backgrounds, patients experience elevated levels of anxiety during 
these appointments which may be due to unfamiliarity with the content (Motulsky et al., 
1994; Biesecker, 1992). This anxiety can also be attributed to patients having to deal with 
complex information while also being confronted with issues that can be frightening and 
sensitive (Motulsky et al., 1994; Chapple et al., 1997).   
Patient satisfaction during an oncology consultation may naturally vary when 
a patient does not receive the news or results they were expecting (Motulsky et al., 
1994). However, even amid unwelcome news, the way information is being delivered 
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may impact a patient’s satisfaction (Motulsky et al., 1994; Chapple et al., 1997; 
Shiloh & Saxe, 1989). One study showed that providing more medical information 
during a counseling appointment may lead to lower satisfaction – possibly due to the 
patient being overwhelmed by unwelcome or extraneous information or the need for a 
patient to ask more questions to get the information they expected to receive (Pieterse 
et al., 2007). However, the same study found that more information can improve 
patients knowledge and recollection (Pieterse et al., 2007). Contrasting this study, 
three other studies stated that receiving more information led to increased levels of 
satisfaction (Hallowell et al., 1997; Motulsky et al., 1994; Chapple et al., 1997). 
These conflicting data between too much information, too little information, and the 
way the information is being delivered can contribute to limited retention and 
comprehension of information provided during a counseling appointment and overall 
patient satisfaction (Motulsky et al., 1994; Chapple et al., 1997; Shiloh & Saxe, 
1989). 
Studies have shown that if patients are not given enough information about a 
counseling appointment, symptom, or test, they may try to do additional research at 
home to answer their questions (Sorenson et al., 1981; Motulsky et al., 1994; Chapple 
et al., 1997; Roche & Skinner, 2009). Unfortunately, individual household web 
searching does not give patients a boundary as to what information is important for 
their own case, often leading to information that is irrelevant, confusing, and alarming 
(Roche & Skinner, 2009). This leads to confusion during a counseling appointment 
when the patient’s own research differs from what the medical professional tells them 
(Roche & Skinner, 2009; Chapple et al., 1997; Motulsky et al., 1994). Patients admit 
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that they are likely to develop their own bias toward information given to them in the 
counseling appointment based on what they themselves have discovered in other 
resources which can further impact their anxiety or satisfaction levels (Roche & 
Skinner, 2009; Chapple et al., 1997). Additionally, this internet-based education may 
persuade more patients to not see a genetic counselor, as they feel fully informed 
(Sorenson et al., 1981; Motulsky et al., 1994). However, if information was given to 
these patients in advance, it might curb their desire to perform their own research or 
guide them to better places of research.  
Beyond research looking at how information or lack of information influences 
patient anxiety and satisfaction levels, previous studies have also shown a general 
demand for providing patients with educational materials prior to a genetic counseling 
appointment (Hallowell et al., 1997). Patients prefer to have information before a 
counseling appointment to better prepare for what to expect (Hallowell et al., 1997). 
Additionally, one study showed that women felt they were inadequately prepared and did 
not know what would happen during a counseling appointment (Hallowell et al., 1997). 
The same study mentions that patients who are unfamiliar with the process of genetic 
counseling may feel limited and unable to ask questions, making them feel inadequately 
prepared (Hallowell et al., 1997). The study suggests that providing patients with written 
information about what will occur during their consultation, possible topics that could be 
discussed in a consultation, as well as some facts about cancer can help them feel more 
prepared (Hallowell et al., 1997). Other studies state that receiving written information 
prior to a consultation can help reduce anxiety and increase patient satisfaction levels 
(Hallowell et al., 1997; Austoker & Ong, 1994; Gibbs & George, 1990). Previous studies 
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have focused on educational materials in the form of pamphlets and print materials 
specializing in genetic testing, BRCA1 and BRCA2 (Cho et al., 1997; Schwartz et al., 
2001). However, studies focusing on the use of a glossary are limited and hard to find. 
Therefore, a glossary could be an appropriate solution. 
 Providing patients with a glossary containing genetics terms will hopefully help 
offer a preview of terminology typically used during a counseling appointment, giving 
patients an idea of what to expect during a counseling appointment and causing a 
decrease in anxiety and an increase in patient satisfaction levels with counseling 
appointments. Additionally, the introduction of a glossary could be a suitable alternative 
for providing prior information of generalized terminology that a patient may hear during 
a counseling appointment. We will explain more in-depth how patient experience affects 
anxiety and satisfaction levels in genetic counseling, the factors and instances that affect 
anxiety and satisfaction levels, and what we propose as a solution. 
HYPOTHESES 
We used a post-counseling survey to assess anxiety and satisfaction levels in 
patients attending a cancer genetic counseling appointment (DeMarco et al., 2004, 
Marteau, 1992, Tluczek, et al., 2009, Julian, L. J., 2011). We hypothesize that 
implementing a glossary prior to a patients’ genetic counseling appointment results in 
a difference in anxiety or satisfaction levels for the experimental group. We predict 
that patients in the experimental group will report higher mean Likert responses for 
the satisfaction survey questions. Additionally, we predict that patients in the 
experimental group who receive a glossary prior to their counseling appointment will 
report higher mean Likert responses for the three positive anxiety traits if they are not 
anxious and lower mean Likert responses for the three negative anxiety traits if they 
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are not anxious. These predictions are founded on the idea that patients who see a 
genetic counselor do not know what is expected from the counseling appointment, 
causing patients to feel anxious and dissatisfied (Pieterse et al., 2005; Pieterse et al., 
2007; Motulsky et al., 1994). The feeling of being informed could possibly make 
patients feel less anxious and more satisfied (Hallowell et al., 1997; Pieterse et al., 
2005; Motulsky et al., 1994). 
METHODS 
Patients 
We recruited patients from the Oncology Genetic Counseling department at 
Banner MD Anderson Cancer Center (BMDACC) in Gilbert, Arizona. We included 
patients who were English speaking, 18 years or older and were attending an initial 
genetic counseling appointment. There was a total of 96 patient participants in this 
study, all of which we obtained informed consent (Appendix A). Additionally, this 
was a single-blind study where the research team collectors knew which patients 
received a glossary and which patients did not, but the counselors did not. This 
removed the possibility of subjective bias from counselors. Patients were given a 
folder that was assigned with either number 1 or 0. Folders assigned number 1 
contained a glossary and folders assigned 0 did not contain a glossary.  
Intervention 
This study implemented a glossary containing genetic terminology as an 
intervention. We collected terms from materials that cancer genetic counselors in the 
Phoenix/Tucson area sent to the research team. We chose the terms based on the 
frequency of use during a standard genetic counseling appointment or by the suggestion 
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of the Phoenix/Tucson genetic counselors. We pulled the definitions from the NHGRI 
“Talking Glossary” database (National Institutes of Health, 2018). A total of ten terms 
were implemented in the glossary: Cancer, DNA, Gene, Tumor Suppressor Gene, 
Mutation, Inherited, Autosomal Dominant, Family History, First Degree Relative, and 
Pedigree (Appendix B). 
Instrument 
To assess patient satisfaction and anxiety, we administered a survey by paper to 
patients after their initial genetic counseling appointment. We based this survey on the 
Genetic Counseling Satisfaction Scale (GCSS) and the shortened 6-item State-Trait 
Anxiety Inventory for adults (STAI-6) (DeMarco et al., 2004; Marteau & Bekker, 1992; 
Tluczek, et al., 2004). Both the GCSS and the STAI-6 are validated Likert scale 
questionnaires- consisting of six questions each- where the GCSS assesses patient 
satisfaction and the STAI-6 assesses patient anxiety levels (DeMarco et al., 2004; 
Marteau & Bekker, 1992; Tluczek, et al., 2004). We chose the GCSS and the STAI-6 
based on their routine use in this field of study and their rigorous validation (DeMarco et 
al., 2004; Marteau & Bekker, 1992; Tluczek, et al., 2004; Julian, 2011). We also included 
two additional socio-demographic questions (education and income levels) in the survey. 
This led to a total of 14 questions on the post-counseling survey (Appendix C). We 
further collected demographic data from patient electronic medical charts: race, ethnicity, 
age, education level, cancer status, cancer type, income level, marital status and gender 
(Table 1). 
Procedure 
8 
 
Upon arrival, a patient’s consent was obtained following a script (Appendix D). 
Each patient was randomly given one of two folders, based on a computerized random 
number generator. One group, the experimental group, was given a packet containing a 
glossary (Appendix B) and an educational document about genetic counseling (Appendix 
E) to read. The second group, the control group, was given a packet containing only the 
educational document (Appendix E). Patients were given approximately five minutes to 
review the packet before it was collected from them. Patients then participated in a 
standard genetic counseling appointment performed by one of two genetic counselors at 
BMDACC, Counselor A or Counselor B. While most patients attended counseling 
appointments with just the genetic counselor, some patients were counseled by a genetic 
counseling second-year student alongside one of the two above certified genetic 
counselors. Other patients had students observing the counseling appointments; however, 
these students did not counsel the patients. At any given time, there was only one extra 
individual in addition to the genetic counselor, the patient, and the patient’s family in the 
consultation rooms during the counseling appointment. At the end of the counseling 
appointment, each patient was given a post-counseling survey by one of two students, 
Collector A or Collector B (Appendix C), both of whom are part of the research team. 
Patients filled out surveys, without any genetic counseling provider, counseling student 
or counseling observer being present. Once the post-counseling survey was filled out, 
there was no further participation required from the patient. 
DATA ANALYSIS 
Data collection took place over a total of six months (mid-July 2017 through mid-
January 2018). We analyzed the satisfaction and anxiety survey responses using the R 
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statistical computing environment, implemented in RStudio (Rstudio Team, 2015; R Core 
Team, 2013). There was no need to perform a normality test or equal variance test 
because of the non-normal distribution nature of Likert Scale responses; the Likert scales 
are bound from 1 to 5 (satisfaction Likert scale) and 1 to 4 (anxiety Likert scale) answer 
options (Norman, 2010; Kamran, 2018; Mangiafico, 2016; Levene, 1960). For the 1 to 5 
satisfaction scale, 1 is associated with, “Strongly Disagree,” with the question presented 
and 5 is associated with, “Strongly Agree,” with the question (Appendix C). For the 1 to 
4 anxiety scale, 1 is associated with feeling, “Not at all,” like the question and 4 is 
associated with feeling, “Very Much,” like the question (Appendix C). The 1 to 5 and 1 
to 4 restricted boundaries are discrete (Norman, 2010; Mangiafico, 2016). Since the aim 
was to compare the groups’ means of the experimental and the control group, we used a 
Welch two-sample t-test, also known as unequal variance test (Lu & Yuan, 2010; Welch, 
1947). It has been shown that Likert scale data can be tested with parametric tests (i.e., t-
tests) and that parametric tests are more robust than non-parametric tests (e.g., Mann 
Whitney U test) (Sullivan & Artino, 2013).  Parametric tests are further recommended 
when performing analysis on patient satisfaction (Sullivan & Artino, 2013). Our data met 
the Welch t-test unequal variance assumption, and even though it did not meet the 
unequal sample size or normality assumption, this test is preferred over the Mann 
Whitney U Test that ranks differences as opposed to the group mean differences (Lani, 
2013).  
RESULTS 
Patient Characteristics 
Demographic information revealed an underrepresentation of minorities: 8.6% of 
the patients identified as a race other than White and 9.7% identified as Hispanic (Table 
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1). The minority data in this study was too small to further analyze. Patient ages ranged 
from 21 to 87, with a mean age of 55. The data consisted of 80.4% females and 19.5% 
males. 
Patient Characteristic: Annual Household Income Status 
Across all six anxiety questions and six satisfaction questions, at a significance 
level of 0.05, there was no difference between the group of patients who make greater 
than $75,000 and the group of patients that make less than $75,000 a year (Table 2) 
Patient Characteristic: Education Level 
At a significance level of 0.05, we found a difference in responses to satisfaction 
questions S3 and S4 between the group of patients who had college experience and the 
group of patients who had no college experience (Table 3). For questions S3 and S4, the 
group of patients who had no college experience reported a higher satisfaction mean 
Likert response (Table 3). We found no difference in anxiety levels between the group of 
patients who had college experience and the group of patients who had no college 
experience.  
Patient Characteristic: Cancer Status 
Across all six anxieties and six satisfaction questions, at a significance level of 
0.05, there was no difference between the group of patients who are affected with cancer 
and the group of patients who are unaffected with cancer (Table 4). 
Anxiety Survey Questions 
Across all six anxiety questions, at a significance level of 0.05, there was no 
difference between the control group that did not receive a glossary and the experimental 
group that did receive a glossary (Table 5). 
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Satisfaction Survey Questions 
Across all six satisfaction questions, at significance level 0.05, we found a 
difference for question S1 between the experimental group that received a glossary and 
the control group that did not receive a glossary (Table 6). The experimental group that 
received a glossary reported a higher satisfaction mean Likert response (Table 6). We 
found no difference in satisfaction levels between the control group that did not receive a 
glossary and the experimental group that did receive a glossary for questions S2-S6 
(Table 6). 
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Table 1. Patient Characteristics. Patient demographics are presented below including 
all data collected from patients’ charts: race, ethnicity, age, education level, cancer status, 
cancer type, annual household income, marital status and gender. 
Characteristics 
Total 
(N=92) 
Gender 
        Males 18 
        Females 74 
Age Range 21-87
Mean Age 55 
Intervention 
       Glossary Group 
       No Glossary Group 
53 
39 
Annual Household Income 
        >$75,000 53 
        <$75,000 39 
Cancer Status 
        Affected Status 59 
        Unaffected Status 33 
Ethnicity 
        Hispanic/ Latino 9 
        No Hispanic/Latino 83 
Education Level 
        8th grade 1 
High School 11 
Partial College 26 
College Graduate 27 
Professional Degree 27 
Marital Status 
Married 63 
Divorce 8 
Single 16 
Widowed 4 
Unknown 1 
Race 
        White 84 
 Black 1 
 Asian 3 
 Middle Eastern 2 
 Native American 
 Other 
1 
1 
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 Table 2. Mean Likert Response for Responses for patient characteristics of annual 
household income status on patient’s anxiety and satisfaction levels. The mean 
differences between patients who made greater than $75,000 a year and patients who 
made less than $75,000 based on the 12 satisfaction and anxiety survey questions asked 
are reported, along with p-values from a Welch’s t-test.  
 Question Mean for 
<$75,000 
Mean for 
>$75,000 
P-value 
A1 I feel Calm 3.41 3.53 0.4863 
A2 I feel Tense 1.56 1.36 0.1689 
A3 I feel Upset 1.15 1.19 0.7444 
A4 I feel Relaxed 3.15 3.26 0.6165 
A5 I feel Content 3.28 3.32 0.8507 
A6 I feel worried 1.59 1.60 0.9347 
  Question Mean for 
<$75,000 
Mean for 
>$75,000 
P-value 
S1 My genetic counselor seemed to 
understand the stresses I was 
facing 
4.82 4.85 0.8465 
S2 My genetic counselor helped me to 
identify what I needed to know to 
make decisions about what would 
happen to me 
4.49 4.40 0.7528 
S3 I felt better about my health after 
meeting with my genetic counselor 
4.62 4.30 0.08346 
S4 The genetic counseling session 
was about the right length of time I 
needed 
4.82 4.85 0.8439 
S5 My genetic counselor was truly 
concerned about my well-being 
4.82 4.89 0.6252 
S6 The genetic counseling session 
was valuable to me 
4.90 4.85 0.35996 
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Table 3. Mean Likert Response for Responses for patient characteristics of 
education level on patient’s anxiety and satisfaction levels. The mean differences 
between patients who had college experience and patients who had no college experience 
based on the 12 satisfaction and anxiety survey questions asked are reported, along with 
p-values from a Welch’s t-test.
Question Mean for College 
Experience 
Mean for No 
College Experience 
P-value
A1 I feel Calm 3.50 3.33 0.6124 
A2 I feel Tense 1.46 1.33 0.4376 
A3 I feel Upset 1.19 1.08 0.325 
A4 I feel Relaxed 3.21 3.25 0.9205 
A5 I feel Content 3.33 3.17 0.647 
A6 I feel worried 1.61 1.50 0.6565 
Question Mean for College 
Experience 
Mean for No 
College Experience 
P-value
S1 My genetic counselor seemed to 
understand the stresses I was 
facing 
4.84 4.83 0.9822 
S2 My genetic counselor helped me to 
identify what I needed to know to 
make decisions about what would 
happen to me 
4.45 4.33 0.8092 
S3 I felt better about my health after 
meeting with my genetic counselor 
4.39 4.75 0.03789 
S4 The genetic counseling session 
was about the right length of time I 
needed 
4.81 5 0.0212 
S5 My genetic counselor was truly 
concerned about my well-being 
4.85 4.92 0.5529 
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Table 4. Mean Likert Response for Responses for patient characteristics of cancer 
status on patient’s anxiety and satisfaction levels. The mean differences between 
patients who are affected with cancer and patients who are unaffected with cancer based 
on the 12 satisfaction and anxiety survey questions asked are reported, along with p-
values from a Welch’s t-test. 
 Question Mean for 
Affected 
Mean for 
Unaffected 
P-value 
A1 I feel Calm 3.49 3.45 0.8274 
A2 I feel Tense 1.34 1.64 0.07164 
A3 I feel Upset 1.17 1.18 0.9149 
A4 I feel Relaxed 3.27 3.12 0.5116 
A5 I feel Content 3.24 3.42 0.349 
A6 I feel worried 1.56 1.67 0.5554 
  Question Mean for 
Affected 
Mean for 
Unaffected 
P-value 
S1 My genetic counselor seemed to 
understand the stresses I was 
facing 
4.85 4.82 0.8532 
S2 My genetic counselor helped me to 
identify what I needed to know to 
make decisions about what would 
happen to me 
4.36 4.58 0.4331 
S3 I felt better about my health after 
meeting with my genetic counselor 
4.41 4.48 0.6663 
S4 The genetic counseling session 
was about the right length of time I 
needed 
4.85 4.82 0.8473 
S5 My genetic counselor was truly 
concerned about my well-being 
4.85 4.88 0.8273 
S6 The genetic counseling session 
was valuable to me 
4.90 4.82 0.5995 
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Table 5. Mean Likert Response for Responses to Anxiety Survey Questions. The 
mean differences for the experimental that received the glossary versus the control group 
that did not receive a glossary based on the six anxiety survey questions asked are 
reported, along with p-values from a Welch’s t-test.  
  Question Mean for Terms Mean for No Terms P-value 
A1 I feel Calm 3.47 3.49 0.9258 
A2 I feel Tense 1.43 1.46 0.8518 
A3 I feel Upset 1.19 1.15 0.7510 
A4 I feel Relaxed 3.06 3.44 0.0702 
A5 I feel Content 3.16 3.51 0.0551 
A6 I feel worried 1.60 1.59 0.9347 
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Table 6. Mean Likert Responses for Responses to Satisfaction Survey Questions. 
The mean differences for the experimental group that received a glossary versus the 
control group that did not receive a glossary based on the six satisfaction survey 
questions asked and p-values from a Welch’s t-test.   
Question Mean for 
Glossary 
Mean for No 
Glossary 
P-value
S1 My genetic counselor seemed to 
understand the stresses I was facing 
4.98 4.64 0.0438 
S2 My genetic counselor helped me to 
identify what I needed to know to 
make decisions about what would 
happen to me 
4.58 4.23 0.2397 
S3 I felt better about my health after 
meeting with my genetic counselor 
4.54 4.28 0.1680 
S4 The genetic counseling session was 
about the right length of time I 
needed 
4.96 4.66 0.0712 
S5 My genetic counselor was truly 
concerned about my well-being 
4.96 4.71 0.1090 
S6 The genetic counseling session was 
valuable to me 
4.92 4.79 0.3924 
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DISCUSSION 
We did not detect a significant difference in patients’ anxiety or satisfaction 
levels for the experimental group who received a glossary versus the control group 
that did not receive a glossary. Additionally, we did not detect a difference in 
patients’ anxiety or satisfaction levels for patients’ annual household income status, 
cancer status and patients’ levels of education.  
Participant Characteristics: Gender, Race and Ethnicity 
Our sample was skewed toward patients who were white, married and had 
post-high school education (Table 1). Also, our sample consisted of patients who 
were largely not Hispanic or Latino, made greater than $75,000 for their annual 
household incomes, were diagnosed with cancer and were mainly females (Table 1). 
There were few non-white individuals in our dataset, and so we did not analyze by 
reported race; underrepresentation in our sample set could have been a result of 
barriers related to income, insurance, education, language or community awareness of 
genetic counseling (Culver et al., 2001; Schwartz et. al, 2001; Cooper, 1990; Allford 
et al., 2014). We had a higher participation rate of women than men, but as we did not 
collect the number of people who did not consent to participate, we do not know 
whether this was a participation bias. Typically, women tend to take more health 
precautions with cancer screenings and have prior knowledge of mainstream genetic 
terminology that increases their interest (Brain et al., 2002; Geller et .al 1999; Sach & 
Whynes, 2009), which could explain the overrepresentation of women in our dataset. 
We assessed patient satisfaction and anxiety levels for were patients based on annual 
household income status, levels of education and cancer status. 
Patient Characteristic: Annual Household Income Status 
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Most of the sample consisted of individuals who made greater than $75,000 a 
year; 57.6% of the patients identified as making greater than $75,000 a year and 42.3% 
identified as making less than $75,000 a year (Table 1).We found that there were no 
differences between all six anxiety questions and all six satisfaction questions for the 
groups of patients that made greater or less than $75,000 a year (Table 2). These results 
are in the same direction as a previous study that found annual household income has no 
effect on patient satisfaction levels (DeMarco et al., 2004). Yet, we observed a trend, an 
observation in which there is a change developing toward a certain direction, in anxiety 
levels for questions A1, A4, A5, A6 where the group of patients that made less than 
$75,000 a year was more anxious than patients who made greater than $75,000 a year 
(Merriam-Webster, 2018; Table 2). Moreover, we found a trend in satisfaction levels, 
where patients who made greater than $75,000 were more satisfied with how the 
counselor helped them, felt better about their health, and thought their genetic counseling 
session was valuable to them (Table 2). However, these same patients reported less 
satisfaction for questions S1, S4, and S6 (Table 2). We did not a have an observed trend, 
for questions that had similar mean values for both groups (Table 2). There is no 
quantitative measure for a trend, therefore, a cutoff cannot be assigned. 
Patient Characteristic: Education Level 
Additionally, most of our sample consisted of individuals who had some post-
high-school education; 86.9% of the patients identified as having had college experience 
and 13.0% of the patients identified as not having any college experience (Table 1). We 
tested for differences between patients who had college experience and patients who did 
not have any college experience. For education level, we found that the mean Likert 
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response for satisfaction was significantly higher for questions S3 and S4 for patients 
who stated not having any college experience (p-value = 0.03789 and p-value 0.0212, 
respectively prior to a multiple test correction) (Noble, 2009) (Table 3). Our observations 
are in contrast with previous research that stated educated patients report higher levels of 
satisfaction (Hall & Dornan, 1990). Furthermore, our data did not match with the results 
of previous literature that reported that people who have not taken a biology class or 
reached higher levels of education (e.g. high school) feel vulnerable throughout a 
counseling appointment due to having difficulties communicating with genetic counselors 
(Chapple et al., 1997), increasing patient anxiety levels. In our sample, the analysis 
showed that patients’ education levels did not affect their anxiety levels, though we may 
have been underpowered to detect such a difference (QFAB, 2018). 
Patient Characteristic: Cancer Status 
Most of our sample consisted of individuals with cancer, 64.1 % of the patients 
identified as being affected by cancer and 35.8% of the patients identified as being 
unaffected by cancer (Table 1). We tested whether there were differences in anxiety and 
satisfaction levels between patients who had a cancer diagnosis and those who did not 
have a cancer diagnosis. We found that there was no difference between being affected or 
unaffected with cancer across all six anxiety questions and all six satisfaction questions 
(Table 4). But, we did find a trend in increased anxiety, where patients who were affected 
with cancer were for the most part less anxious than patients who were affected with 
cancer (Table 4).  There was one question, A2 (I feel content), where the group of 
patients that did have cancer was more anxious. Additionally, we found a trend in 
increased satisfaction levels for patients who were affected with cancer for questions 
S1, 
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S4, and S6 (Table 4). However, this same group of patients also showed a trend of feeling 
less satisfaction for questions S2, S3, and S5(Table 4). We did not a have an observed 
trend, for questions that had similar mean values for both groups (Table 4). Our results 
were in the same direction as a previous study finding that there is no difference in 
affected or unaffected cancer status in patient satisfaction levels (DeMarco et al., 2004). 
However, our observations are in contrast with previous research that states patients who 
have cancer report higher levels of anxiety (Hamang et al., 2012). Our inability to detect 
a difference could be due to our studies small sample size and lower statistical power 
(QFAB, 2018).  
Anxiety Survey 
In this study, we tested whether the experimental group that received the glossary 
had less anxiety than the control group that did not receive the glossary. We found that 
there was no difference between the control and the experimental group across all six 
anxiety questions (Table 5). But we did find a trend for question A4 (I feel Relaxed) and 
A5 (I feel Content) where patients who received a glossary were more anxious than 
patients that did not receive a glossary (A4 p-value= 0.0702 and A5 p-value= 0.0551 
respectively) (Table 5). Our results differed from studies that found, the feeling of being 
informed could possibly make patients feel less anxious and more satisfied (Pieterse et 
al., 2005; Pieterse et al., 2007; Motulsky et al., 1994). Ultimately, just like annual 
household income and cancer status, the lack of difference detected in the present study 
could stem from low statistical power and small sample size (QFAB, 2018).  
Satisfaction Survey 
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We also tested whether individuals in the experimental group that received the 
glossary were more satisfied compared to those in the control group that did not 
receive the glossary. We found that the mean Likert response was significantly higher 
for the experimental group (mean = 4.98; Table 6) compared to the control group 
(mean = 4.64; Table 6) for question S1, indicating that the experimental group who 
received the glossary was more satisfied, when only this question was considered 
(Table 6). The difference for satisfaction question S1 is statistically significant with a 
p-value of 0.0438, but only prior to multiple test correction (Table 6). Just like
education level, we did not perform this multiple test correction and if it had been 
done, the significant difference would no longer be present (Noble, 2009). This result 
difference was in the same direction as a previous study finding that being informed 
increased satisfaction levels (Hallowell et al., 1997; Motulsky et al., 1994; Chapple et 
al., 1997; Pieterse et al., 2005).  
CONCLUSION 
This study assessed the use of a glossary containing genetic terminology on 
patient satisfaction and anxiety levels in an oncology genetic clinic. We did not observe 
differences in patient satisfaction and anxiety levels. We suggest that future studies 
attempt similar analyses with a larger sample size, a longer collection period, and in 
different settings. 
LIMITATIONS 
There are several limitations of the current study design. First, we had a low 
sample size that prevented us from having the power to detect small effects of the 
intervention. Second, additional family members were present at the time the survey 
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was administered, which may have influenced survey responses. Third, it is possible 
that biases could have unintentionally been introduced if patients indicated that they 
read the glossary or the educational document to the genetic counselor. Fourth, 
patients were not monitored while reading their educational materials, it is possible 
they did not read the entire glossary prior to their counseling appointment and did not 
gain the full potential benefit of the intervention. We feel that these limitations can be 
addressed in future studies. 
FUTURE RECOMMENDATIONS 
We strongly recommend that future studies use a larger sample size to assess the 
effect of this survey with better statistical power. Additionally, future studies could 
implement a pre-counseling survey of satisfaction and anxiety levels; this way an 
assessment could be made on their initial anxiety state as compared to their post-
counseling anxiety state. It would also be interesting to analyze patients’ understanding 
of educational material reviewed during a counseling appointment with the aid of the 
glossary. Lastly, another suggestion would be to further investigate transportation, 
accessibility, and other demographic factors such as race and ethnicity that could directly 
or indirectly affect a patient’s ability to attend and their attitudes towards a genetic 
counseling appointment.  
 
24 
REFERENCES 
Allford, A., Qureshi, N., Barwell, J., Lewis, C., & Kai, J. (2014). What hinders minority 
ethnic access to cancer genetics services and what may help?. European Journal 
of Human Genetics, 22(7), 866. 
Austoker, J., & Ong, G. (1994). Written information needs of women who are recalled 
for further investigation of breast screening: results of a multicentre study. 
Journal of Medical Screening, 1(4), 238-244. 
Biesecker, B. 1992. (published in 1994). Issues in genetic counseling for prenatal 
diagnosis. In Fullarton, J., editor. (ed.) Proceedings of the Committee on 
Assessing Genetic Risks. Washington, D.C.: National Academy Press. 
Brain, K., Norman, P., Gray, J., Rogers, C., Mansel, R., & Harper, P. (2002). A 
randomized trial of specialist genetic assessment: psychological impact on women 
at different levels of familial breast cancer risk. British journal of cancer, 86(2), 
233. 
Chapple, A., Campion, P., & May, C. (1997). Clinical terminology: anxiety and 
confusion amongst families undergoing genetic counseling. Patient Education 
and Counseling, 32(1), 81-91. 
Cho, M. K., Arruda, M., & Holtzman, N. A. (1997). Educational material about genetic 
tests: does it provide key information for patients and practitioners?. American 
Journal of Medical Genetics Part A, 73(3), 314-320. 
Childs, B., et al. 1976. Tay-Sachs screening: Motives for participating and knowledge of 
genetics and probability. American Journal of Human Genetics 28:537-49. 
Cooper, P. S. (1990). The effects of ethnocultural background on access to and use of 
genetic services. Unequal opportunity. Birth defects original article series, 26(2), 
46-48.
Culver, J., Burke, W., Yasui, Y., Durfy, S., & Press, N. (2001). Participation in breast 
cancer genetic counseling: the influence of educational level, ethnic background, 
and risk perception. Journal of Genetic Counseling, 10(3), 215-231. 
DeMarco, T. A., Peshkin, B. N., Mars, B. D., & Tercyak, K. P. (2004). Patient 
satisfaction with cancer genetic counseling: a psychometric analysis of the 
Genetic Counseling Satisfaction Scale. Journal of Genetic Counseling, 13(4), 
293-304.
Geller, G., Doksum, T., Bernhardt, B. A., & Metz, S. A. (1999). Participation in breast 
cancer susceptibility testing protocols: influence of recruitment source, altruism, 
and family involvement on women’s decisions. Cancer Epidemiology and 
Prevention Biomarkers, 8(4), 377-383.  
25 
Gibbs, S., Waters, W. E., & George, C. F. (1990). Communicating information to patients 
about medicine. Journal of the Royal Society of Medicine, 83(5). 
Hall, J. A., & Dornan, M. C. (1990). Patient sociodemographic characteristics as 
predictors of satisfaction with medical care: a meta-analysis. Social science & 
medicine, 30(7), 811-818. 
Hallowell, N., Murton, F., Statham, H., Green, J. M., & Richards, M. P. M. (1997). 
Women's need for information before attending genetic counselling for familial 
breast or ovarian cancer: a questionnaire, interview, and observational 
study. Bmj, 314(7076), 281. 
Hamang, A., Eide, G. E., Rokne, B., Nordin, K., Bjorvatn, C., & Øyen, N. (2012). 
Predictors of heart-focused anxiety in patients undergoing genetic investigation 
and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year 
follow-up. Journal of genetic counseling, 21(1), 72-84. 
Julian, L. J. (2011). Measures of anxiety: State‐Trait Anxiety Inventory (STAI), Beck 
Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale‐Anxiety 
(HADS‐A). Arthritis care & research, 63(S11). 
Kamran (https://stats.stackexchange.com/users/62167/kamran), How to judge if 5 point 
Likert scale data are normally distributed?, URL (version: 2014-12-06): 
https://stats.stackexchange.com/q/126788. 
Kessler, S. (1989). Psychological aspects of genetic counseling: VI. A critical review of 
the literature dealing with education and reproduction. American Journal of 
Medical Genetics Part A, 34(3), 340-353. 
Kessler, S., editor. (ed.). 1979. Genetic Counseling: Psychological Dimensions. New 
York: Academic Press. 
Lani, J. (2013). Mann-Whitney U Test. 
Levene, Howard (1960). "Robust tests for equality of variances". In Ingram Olkin; 
Harold Hotelling; et al. Contributions to Probability and Statistics: Essays in 
Honor of Harold Hotelling. Stanford University Press. pp. 278–292. 
Lu, Zhenqiu & Yuan, Ke-Hai. (2010). Welch's t test. 1620-1623. 
10.13140/RG.2.1.3057.9607. 
Mangiafico, S. (2016). Summary and Analysis of Extension Program Evaluation in R. 
https://www.researchgate.net/post/Why_data_on_5-
point_Likert_scales_are_never_normally_distributed. 
Marteau, T. M., & Bekker, H. (1992). The development of a six‐item short‐form of the 
state scale of the Spielberger State—Trait Anxiety Inventory (STAI). British 
Journal of Clinical Psychology, 31(3), 301-306. 
26 
Merriam-Webster. Trend. 2011. In Merriam-Webster.com. Retrieved April 19, 2018, 
from https://www.merriam-webster.com/dictionary/trend 
Motulsky, A. G., Holtzman, N. A., Fullarton, J. E., & Andrews, L. B. (Eds.). (1994). 
Assessing genetic risks: implications for health and social policy (Vol. 1). 
National Academies Press. 
National Institutes of Health. National Human Genome Research Institute. “Talking 
Glossary of Genetic Terms.” Retrieved March 19, 2018, from 
https://www.genome.gov/glossary/ 
Noble, W. S. (2009). How does multiple testing correction work?. Nature biotechnology, 
27(12), 1135. 
Norman, G. (2010). Likert scales, levels of measurement and the “laws” of statistics. 
Advances in Health Sciences Education, 15(5), 625–632. 
Pieterse, A. H., Ausems, M. G., Van Dulmen, A. M., Beemer, F. A., & Bensing, J. M. 
(2005). Initial cancer genetic counseling consultation: change in counselees' 
cognitions and anxiety, and association with addressing their needs and 
preferences. American journal of medical genetics Part A, 137(1), 27-35. 
Pieterse, A. H., Van Dulmen, A. M., Beemer, F. A., Bensing, J. M., & Ausems, M. G. 
(2007). Cancer genetic counseling: communication and counselees’ post-visit 
satisfaction, cognitions, anxiety, and needs fulfillment. Journal of Genetic 
Counseling, 16(1), 85-96. 
QFAB. (2018). ANZMTG Statistical Decision Tree, Power Calculator (Version 1.0 (Web 
Application). 
R Core Team (2013). R: A language and environment for statistical computing. R 
Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-
project.org/. 
Resta, R., Biesecker, B. B., Bennett, R. L., Blum, S., Hahn, S. E., Strecker, M. N., & 
Williams, J. L. (2006). A new definition of genetic counseling: National Society 
of Genetic Counselors’ task force report. Journal of genetic counseling, 15(2), 77-
83. 
Roche, M. I., & Skinner, D. (2009). How parents search, interpret, and evaluate genetic 
information obtained from the internet. Journal of genetic counseling, 18(2), 119-
129. 
Sach, T. H., & Whynes, D. K. (2009). Men and women: beliefs about cancer and about 
screening. BMC Public Health, 9(1), 431. 
Shiloh, S., & Saxe, L. (1989). Perception of risk in genetic counseling. Psychology and 
Health, 3(1), 45-61. 
27 
Schwartz, M. D., Benkendorf, J., Lerman, C., Isaacs, C., Ryan‐Robertson, A., & Johnson, 
L. (2001). Impact of educational print materials on knowledge, attitudes, and
interest in BRCA1/BRCA2. Cancer, 92(4), 932-940.
Sorenson, J. R., Swazey, J. P., Scotch, N. A., Kavanagh, C. M., & Matthews, D. B. 
(1981). Reproductive pasts, reproductive futures. Genetic counseling and its 
effectiveness. Birth defects original article series, 17(4), 1-192. 
Sullivan, G. M., & Artino Jr, A. R. (2013). Analyzing and interpreting data from Likert-
type scales. Journal of graduate medical education, 5(4), 541-542. 
Tluczek, A., Henriques, J. B., & Brown, R. L. (2009). Support for the reliability and 
validity of a six-item state anxiety scale derived from the State-Trait Anxiety 
Inventory. Journal of nursing measurement, 17(1), 19. 
Welch, B. L. (1947). The generalization of students' problem when several different 
population variances are involved. Biometrika, 34(1/2), 28-35. 
28 
 
APPENDIX A 
CONSENT FORM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Informed Consent to Participate in Research 
and HIPAA Authorization 
Assessment of patient satisfaction and anxiety level in an oncology genetic 
counseling clinic 
Banner MD Anderson Cancer Center 
 Rebecca Luiten, MS, CGC 
29 
INVITATION TO PARTICIPATE 
You are being asked to take part in this study because you are attending a cancer genetic 
counseling session. 
This is a cancer genetic counseling research study. Research studies include only patients 
who choose to take part. Please take your time to make your decision.  
WHY IS THIS STUDY BEING DONE? 
To investigate way to improve patient satisfaction and reduce anxiety in oncology genetic 
counseling. 
HOW MANY PEOPLE WILL TAKE PART IN THIS STUDY? 
About 300 people will take part in this study. All participants will take part in the study at 
this site. 
WHAT IS INVOLVED IN THIS STUDY? 
You will receive education documents to review prior to your appointment with the genetic 
counselor. You will receive a standard genetic counseling session and will be given a 
survey to fill out after your appointment. This survey will help investigate ways to improve 
genetic counseling. The genetic counselor will not see the results of the survey. Beyond 
this, no active participation from you is required.  
HOW LONG WILL YOU BE ON THE STUDY? 
● Your participation in this study will last the duration of your genetic counseling
appointment. After completion of your appointment, no other active participation
will be necessary
● This study will analyze data collected from May 1, 2017 through September 30,
2017; however, your active participation will conclude today. There will be no
follow-ups conducted for this study.
WHAT ARE THE RISKS? 
This project has no anticipated risks. 
ARE THERE BENEFITS TO TAKING PART IN THIS STUDY? 
There are no direct benefits to you for enrolling in this study, other than the knowledge that 
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you are contributing to scientific inquiry. We hope the information learned from this study 
will benefit other patients in the future. 
 
WHAT OTHER OPTIONS ARE THERE? 
Instead of being in this study, you have these options: 
● Other than this study, there are no current ongoing genetic counseling research 
studies at BMDACC; however, you may always decline participation in this study. 
 
WHAT ABOUT CONFIDENTIALITY? 
Efforts will be made to keep your personal information private and confidential; however, 
we cannot guarantee absolute privacy and confidentiality. 
 
Your private health information may be disclosed if required by law and/or following 
completion of the authorization at the end of this document from you giving your 
permission to release select private health information to certain individuals associated 
with this research. The individuals associated with this study who will receive your private 
health information include: 
● The research team 
● Banner Health, including the Banner Health Institutional Review Board 
● The sponsor of the study: Melissa Wilson Sayres, PhD 
● The contract research organization (CRO): Banner MD Anderson Cancer 
Center 
● The site management organization: Banner MD Anderson Cancer Center  
● Data analysis center: Melissa Wilson Sayres’ lab at Arizona State University 
● A core laboratory for genomics, evolution and bioinformatics.  
● A central laboratory for Arizona State University School of Life Sciences  
● No other research entities will be given your private health information. Your 
private health information will be de-identified and seen only by the student 
coordinator and primary investigator.  
 
WHAT ARE THE COSTS? 
There is no cost associated to you as a result of participating in the project. You will be 
responsible for all co-pays and deductibles associated with routine care billable to 
insurance. 
 
IS THERE COMPENSATION FOR PARTICIPATING? 
No compensation will be given to you for participating.  
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WHAT ABOUT COMPENSATION FOR MY DOCTOR? 
There is no compensation for your physicians or genetic counselors. 
 
WHAT HAPPENS IF YOU ARE INJURED? 
In the case of injury or illness resulting from this study, emergency medical treatment is 
available from Banner Gateway Medical Center, but will be provided at the usual charge. 
No funds have been set aside to compensate you in the event of injury.  You or your 
insurance company will be charged for continuing medical care and/or hospitalization. 
 
We do not anticipate an injuries as a result of participating in this study. 
 
This does not waive your rights in the event of negligence. 
 
WHAT ARE YOUR RIGHTS AS A PARTICIPANT? 
Taking part in this study is voluntary. You may choose not to take part or may leave the 
study at any time. Leaving the study will not result in any penalty or loss of benefits to 
which you are entitled. 
 
We will tell you about new information developed during the course of the study that may 
affect your health, welfare, or willingness to stay in this study. 
 
CAN YOU BE REMOVED FROM THE STUDY? 
For your safety, your participation may be terminated by your physician at any time without 
your consent. Your participation would also be terminated if you choose to not take the 
post-counseling survey. You are free to withdraw from the study at any time. No safety 
precautions are needed after a withdrawal or termination of participation. You are free to 
participate in other research projects while enrolled in this project. 
 
WHOM DO YOU CALL IF YOU HAVE QUESTIONS? 
For questions about the study or a research-related injury, contact the researcher Melissa 
Wilson Sayres at 814-321-6416 or Lidia Peon at (760)-585-5214.  
 
If you have any questions about your rights as a research participant, contact the Banner 
Health Human Subject Protection Administrator at 602-839-4583, Monday through Friday, 
from 9AM to 5PM. This study has been approved by a panel of the Banner Health 
Institutional Review Board (IRB). 
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Authorization to Use Your Health Information for Research Purposes 
 
WHAT IS THE PURPOSE OF THIS FORM? 
The federal medical HIPAA Privacy Rule protects your personal health information (PHI). 
The purpose of this form is to inform you about how your PHI will be used or disclosed 
(given out) in this research study. In order for the research team to use and give out your 
PHI, your written permission, called your “authorization”, is needed. 
If you sign this form, you give permission to the research team to use and/or disclose your 
PHI as described in the attached consent form. Please consider the important information 
in this form prior to making your decision. 
If you have any questions or concerns about this authorization you should contact Sue 
Colvin, Banner Research Regulatory Affairs Program Director at (602) 839-4583 or 
sue.colvin@bannerhealth.com. You may also request and will be provided a copy of the 
Notice of Privacy Practices. 
 
WHAT PHI WILL BE OBTAINED, USED OR DISCLOSED? 
The following is a description of your PHI you are authorizing to be used and/or disclosed 
in connection with this research study:  
☐  Entire Official Medical/Clinical Record (including all boxes in this table) 
☐ Assessments 
☐ Discharge 
Summaries 
☐ Interviews ☐ Operative Reports 
☐ Primary Care 
Physician 
Records 
☐ Audiology 
Records 
☐ EEG Reports 
☐ Laboratory 
Reports 
☐ Outpatient Clinic 
Records 
☐ Problem List 
(electronic 
medical record) 
☐ Autopsy 
Reports 
☐ EKG 
Reports 
☐ Medicare 
Records 
☐ Ophthalmology 
Records 
☐ Progress Notes 
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☐ Consultation 
Reports 
☐ Emergency 
Medicine 
Reports 
☐ Medication 
Lists 
☐ Pathology Reports ☐ Questionnaire 
☐ Demographic 
Information 
☐ Genetic 
Testing 
☐ Neuropsych 
Test Results 
☐ Pathology Slides 
☐ Recordings 
(Audio/Video)/ 
Photographs 
☐ Dental Records 
☐ Healthcare 
Billing 
Records 
☐ Nursing Notes 
☐ Pathology 
Specimens 
☐ Survey 
☐ Diagnostic 
Imaging 
Reports/Films/ 
CDs/Scans 
☐ History & 
Physical 
Exams 
☐ Occupational 
Therapy  
Records 
☐ Physical Therapy 
Records 
☐ Vocational Test 
Results 
☐ Other:  
Information related to this research study that identifies you and your PHI will be collected 
from your past, present, and future hospital and/or other health care provider medical 
records. The demographic information to be disclosed may include, but is not limited to, 
your name, address, phone number, or social security number. If you receive compensation 
for participating in this research study, information identifying you may be used or 
disclosed as necessary to provide that compensation. 
 
Your existing health records may include information related to the diagnosis or treatment 
of Sexually Transmitted Disease (STD), Acquired Immunodeficiency Syndrome (AIDS), 
Human Immunodeficiency Virus (HIV), Other Communicable Diseases (except as 
described in d. above), Genetic Information (e.g., Genetic Testing), and Treatment of 
Alcohol and/or Drug Abuse. The research team may see this information while 
reviewing your regular health records for this study, but they WILL NOT create, 
collect, use, or disclose this type of information for the purposes of the research. 
 
WHO WILL USE AND/OR DISCLOSE YOUR PHI? 
The following parties are authorized to use and/or disclose your PHI for the research 
described in the attached consent form: 
a. The primary investigator and the study coordinator 
b. Banner Health 
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WHO MAY RECEIVE YOUR PHI? 
The parties listed in the preceding paragraph may disclose your health information to the 
following persons and organizations for their use in connection with this research study: 
a. Melissa Wilson Sayres and her agents or study monitors  
b. Banner Health IRB 
 
Your PHI may no longer be protected under the HIPAA privacy rule once it is disclosed 
by the research team to these other parties.  
 
WHAT PURPOSES ARE YOU AUTHORIZING THE USE AND/OR 
DISCLOSURE OF YOUR PHI? 
a. To conduct the study described earlier in this document 
b. Oversight, audit and monitoring of the study 
 
WHEN WILL MY AUTHORIZATION EXPIRE? 
There is no expiration date or event for your authorization. Therefore, unless you cancel 
this authorization (as instructed below) this authorization will continue to be effective. 
 
DO YOU HAVE TO SIGN THIS AUTHORIZATION FORM? 
You do not have to sign this authorization. However, if you decide not to sign, you will not 
be able to participate in this research study. If you do not sign, it will not affect any non-
study Banner Health medical treatment or health care, payment, enrollment in any health 
plans, or benefits. 
 
 
WHAT DO YOU NEED TO KNOW IF YOU DECIDE TO CANCEL YOUR 
AUTHORIZATION? 
After signing the authorization, you may decide to cancel your permission to use your PHI. 
If you cancel the authorization, you will no longer be able to stay in the research study. 
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Any PHI collected before you cancel the authorization may still be used by the research 
team and recipients described above to maintain the integrity or reliability of the research 
study. The research team is required by law to report any bad side effect you experience 
even if you have canceled your authorization. 
 
HOW DO YOU CANCEL YOUR AUTHORIZATION? 
To cancel this authorization you must notify the principal investigator in writing at the 
following address: 
Melissa Wilson Sayres 
Arizona State University  
Po Box 874501 
Tempe, Az 85287-4501 
melissa.wilsonsayres@asu.edu  
 
WILL ACCESS TO YOUR MEDICAL RECORD BE LIMITED DURING THE 
STUDY? 
To maintain the integrity of this research study, you may not have access to any health 
information developed as part of this study until it is completed. At that point, you would 
have access to such health information if it was used to make a medical or billing decision 
about you (e.g., if included in your official medical record).  
 
WHAT OTHER INFORMATION DO YOU NEED TO KNOW? 
If you choose to sign this Authorization, the disclosure or transfer of your PHI will result 
in payment/compensation to Banner Health. Additionally, the disclosure or transfer of your 
PHI by any person or entity identified above will also result in payment/compensation to 
such person or entity. 
 
SIGNING THE CONSENT FORM 
 
I have read (or someone has read to me) this form, and I am aware that I am being asked 
to participate in a research study. I have had the opportunity to ask questions and have had 
them answered to my satisfaction. I voluntarily agree to participate in this study and I 
            Informed Consent to Participate in Research 
and HIPAA Authorization 
 
Assessment of patient satisfaction and anxiety level in an oncology genetic 
counseling clinic 
Banner MD Anderson Cancer Center 
 Rebecca Luiten, MS, CGC 
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authorize the use and/or disclosure of my PHI. 
 
I am not giving up any legal rights by signing this form. I will be given a signed copy of 
this form. 
 
 
 
    
Printed name of subject  Signature of subject  Date 
 
 
 
    
Printed name of person 
authorized to consent for 
subject 
 Signature of person authorized to 
consent for subject 
 Date 
 
  
Relationship to the subject  
 
Investigator/Research Staff 
I have explained the research to the subject or the subject’s representative before requesting 
the signature(s) above. There are no blanks in this document. A signed copy of this form 
has been given to the subject or to the subject’s representative. 
 
 
 
    
Printed name of person 
obtaining consent 
 Signature of person obtaining consent  Date 
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Genetics Terms List 
 
DNA: DNA is the chemical name for the molecule that carries genetic instructions in all living 
things. 
 
Gene: The gene is the basic physical unit of inheritance. Genes are passed from parent to offspring 
and contain the information needed to specify traits (physical characteristics). Genes are arranged, 
one after another, on structures called chromosomes. 
 
Mutation: A mutation is a change in the DNA sequence.  
 
Inherited: An inherited trait is one that is genetically determined. Inherited traits are passed from 
parent to offspring according to the rules of Mendelian genetics. Most traits are not strictly 
determined by genes, but rather are influenced by both genes and environment. 
 
Cancer: Cancer is a group of diseases characterized by uncontrolled cell growth. Cancer begins 
when a single cell mutates, resulting in a breakdown of the normal regulatory controls that keep 
cell division in check. These mutations can be inherited, caused by errors in DNA replication, or 
result from exposure to harmful chemicals. A cancerous tumor can spread to other parts of the 
body, which is called a metastasis. 
 
Tumor Suppressor Gene: A tumor suppressor gene directs the production of a protein that is part 
of the system that regulates cell division. The tumor suppressor protein plays a role in keeping cell 
division in check. When mutated, a tumor suppressor gene is unable to do its job, and as a result 
uncontrolled cell growth may occur. This may contribute to the development of cancer. 
 
Autosomal Dominant: Autosomal dominant is a pattern of inheritance characteristic of some 
genetic diseases. “Autosomal” means that the gene in question is located on one of the numbered, 
or non-sex, chromosomes. “Dominant” means that a single copy of the disease-associated mutation 
is enough to cause the disease. This is in contrast to a recessive disorder, where two copies of the 
mutation are needed to cause the disease.  
 
Family History: A family history is a record of medical information about an individual and their 
biological family. 
 
First Degree Relative: A first degree relative is a family member who shares about 50 percent of 
their genes with a particular individual in a family. First degree relatives include parents, offspring, 
and siblings. 
 
Pedigree: A pedigree is a genetic representation of a family tree that diagrams the inheritance of a 
trait or disease through several generations. The pedigree shows the relationship between family 
members and indicates which individuals express or silently carry the trait in question. 
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Instructions. In an effort to continuously monitor and improve the quality of genetic counseling services delivered to patients 
at this healthcare organization, please take a moment to fill-out this form regarding the appointment you just completed with 
your genetic counseling professional. Please read each statement below very carefully, and tell us how much you agree or 
disagree with each statement by circling your response on the scale to the right. Your honest responses will be kept strictly 
confidential, and they will not be shared with your genetic counseling professional. Thank you for assisting us. 
 
Please circle the answers that best describes your agreement with the statement: 
Q 
 
 Strongly 
Agree 
Disagree 
Somewhat 
Uncertain Agree 
Somewhat 
Agree 
Strongly 
1 My genetic counselor seemed to 
understand the stresses I was 
facing 
1 2 3 4 5 
2 My genetic counselor helped me to 
identify what I needed to know to 
make decisions about what would 
happen to me 
1 2 3 4 5 
3 I felt better about my health after 
meeting with my genetic counselor 
1 2 3 4 5 
4 The genetic counseling session was 
about the right length of time I 
needed 
1 2 3 4 5 
5 My genetic counselor was truly 
concerned about my well-being 
1 2 3 4 5 
6 The genetic counseling session was 
valuable to me 
1 2 3 4 5 
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Please circle the answers that most describes your current state: 
Q Not at all Somewhat Moderately Very Much 
7 I feel calm 1 2 3 4 
8 I feel tense 1 2 3 4 
9 I feel upset 1 2 3 4 
10 I feel relaxed 1 2 3 4 
11 I feel content 1 2 3 4 
12 I feel worried 1 2 3 4 
Please circle the answer that applies to you: 
13 Highest level of education 
completed 
High School Partial College College graduate Professional degree 
14 Annual household income Less than or 
equal to 
$75,000 
Greater than 
$75,000 
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Assessment of genetic terms list on patient satisfaction and anxiety level in an oncology 
genetic counseling clinic 
Melissa Wilson-Sayres, PhD, Lidia Peon, Rebecca Luiten MS CGC, Jennifer Siettmann 
MS CGC, Ken Buetow, PhD 
 
Scripts for Patient Communication 
 
1. Script for calling patients ahead of the study 
 
Hello, my name is Lidia Peon and I am calling about your genetic counseling 
appointment at Banner MD Anderson scheduled for DATE at TIME. I am a graduate 
student at Arizona State University and I’m working on a research project with the 
genetic counselors at Banner MD Anderson to investigate ways to improve the genetic 
counseling experience. In order to do that, we were hoping you would be willing to show 
up 15 minutes early to your appointment to review some information with me prior to 
seeing the genetic counselor. This is all voluntary, so if you’re not able to arrive early, 
that’s completely fine and you’ll still receive the same quality of genetic counseling.  
1. Patient indicates agreement 
a. Great, thank you for your interest in this project. We will see you 
at NEW TIME on DATE. 
2. Patient says they can’t come early 
a. That’s fine, I completely understand: I know you probably have a 
busy schedule right now. We’ll see you at your scheduled 
appointment time on DATE at TIME. 
3. Patient asks questions about genetic counseling/cancer/genes 
a. That is a great question: unfortunately, I am not a genetic 
counselor and can’t answer that for you. This would be a great 
question to ask them when you see them on DATE. 
4. Patient asks questions about purpose of appointment or why she even 
needs to come 
a. Unfortunately, I am not a genetic counselor so I can’t answer that 
for you, but I can let COUNSELOR know that you have this 
question and they can call you before your appointment. 
5. Patient asks questions about billing/cost/coverage 
a. Unfortunately, I don’t have the answer to that question, but you 
can call the main clinic line to get in touch with PFS and they can 
answer that question for you. The main clinic line is 480-256-6444. 
6. Patient wants to cancel/reschedule appointment 
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a. I’m sorry to hear that. I can’t cancel that appointment for you, but 
I’ll let one of the genetic counselors know and they will follow-up 
with that. 
 
 
2. Script for handing out the materials and informed consent 
 
Hello, my name is Lidia Peon and I am a graduate student at Arizona State University. 
I’m working with the genetic counselors here at BMDACC on a research project to 
investigate ways to improve the genetic counseling experience. I was hoping that you 
would be able to take a couple minutes to be part of my research project.  
 
 
ALL PARTICIPANTS  
If you agree to participate, your involvement would be pretty minimal.  I am going to 
give you packet to read over before your appointment. After that, you will see your 
genetic counselor just like usual, but after the appointment, your genetic counselor will 
step out of the room and I will enter to give you a post-counseling survey about how you 
feel after the genetic counseling appointment. And that would be all; there’s no additional 
follow-up needed. 
 
Does this sound like something you would be interested in doing? 
 
NO 
Okay, that’s not a problem. I’ll let the genetic counselor know that you’re here and she’ll 
take you back shortly. 
 
YES 
Great, thank you for your interest! I’m going to read through this informed consent with 
you. Afterwards, please ask any questions that you have about the information in the 
consent and then sign it. 
 
 
 
3. Script for handing out/collecting the survey. 
 (Handing out survey) 
Hi there, 
  
Thank you again for participating in this research. It really means a lot to us. Here is the 
post-counseling survey. Feel free to answer truthfully: your genetic counselor will not see 
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the results of this survey. On this survey, please circle/select the number that 
appropriately describes how you feel right now. 
 
(Collect Survey) 
Thank you for filling out the survey. I wasn’t able to tell you before, but the goal of this 
study is to can see whether having a glossary handed to patients before a session will help 
increase patient satisfaction and reduce anxiety. Your participation has helped my 
research tremendously and will hopefully help  influence future policy by demonstrating 
the benefit of providing patients with the glossary prior to their appointment.  
 
Do you have any additional questions before I tell your genetic counselor she can come 
back into the room? 
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What is Genetic Counseling? 
Your doctor may ask you to meet with a genetic counselor. Many people have not heard of this 
service before. During a genetic counseling session at Banner MD Anderson Cancer Center, the 
genetic counselor will: 
• look at your health record.
• ask you questions about your family history of cancer and sometimes other health issues.
• use these facts to estimate the chance that you could have an inherited condition that
causes a higher than usual risk for cancer.
• talk to you about genetic testing if needed.
The genetic counselor will explain how genetics and family history can affect cancer risks. He or she 
will help you understand your own risk and help you make choices that are best for you. Such as, if 
you are found to be at a greater risk for cancer, the genetic counselor can tell you about more cancer 
testing and prevention options that are available. 
Who are genetic counselors? 
Genetic counselors are health care experts with graduate degrees and experience in the areas of medical 
genetics and counseling. Most counselors enter the field with a background in biology, genetics, 
nursing, psychology, public health or social work. 
Should I think about having cancer genetic counseling? 
You should think about seeing a genetic counselor for a cancer risk assessment if you and/or your 
family history has any of these risk factors: 
• Cancer before age 50
• One person in your family has two or more different cancers
• Two or more close family members have the same or related type of cancer
• Several generations of your family have the same or related type of cancer
• A family member of Ashkenazi Jewish ancestry (Eastern or Central European) who
has breast, ovarian or colorectal cancer
• You or your family members have had multiple polyps
• Certain rare cancers, such as male breast cancer, retinoblastoma (eye cancer),
medullary thyroid cancer or pheochromocytoma/paraganglioma
• A family member with a genetic test diagnosing a hereditary cancer syndrome
• Fear about getting cancer because of family history
If you are interested in having a cancer risk assessment, please call the Banner MD Anderson Cancer 
Center at 
(480) 256-6444 and ask to speak to the Genetic Counselor.
What is Genetic Counseling? © 2005, 2012 The University of Texas MD Anderson Cancer Center, Revised 08/28/12 Patient Education Office.
Banner MD Anderson Cancer Center, Revised, 08/14/2012, 7/2/2015 .Banner MD Anderson Cancer Center  2946 E. Banner Gateway Dr. 
Gilbert, AZ  85234 (480) 256-6444 www.bannermdanderson.com 
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APPENDIX F 
IRB APPROVAL 
 
FWA #00002630 
IORG #0004299 
July 13, 2017 
Rebecca Luiten 
Attn: Alicja M Ball/Amelia Larsen 
Jasmine Neumann/Stephanie Henkel 
Banner MD Anderson Cancer Center  
2946 E. Banner Gateway Drive Ste.375 
Gilbert, AZ 85234 
RE: Project # 14-17-0026  Assessment of genetic terms list on patient satisfaction and anxiety level 
in an oncology genetic counseling clinic   
iRIS Reference # 018409 
IRB Expedited Approval – New Protocol (Version 1.1 dated 6/28/17), Informed Consent and 
HIPAA Authorization (Version 1.2 dated 7/5/17), Master Log (Version 1.0 dated 6/13/17), 
What is Genetic Counseling Flyer (dated 7/2/15), Genetic Terms List (Version 1.0 dated 
6/13/17), Post Counseling Survey (Version 1.0 dated 6/13/17), Scripts for Patient 
Communication (Version 1.0 dated 6/13/17), Data Collection Form (Version 1.0 dated 
6/13/17) 
Dear Ms. Luiten: 
This letter serves to notify you the above referenced Protocol, Informed Consent, and HIPAA 
Authorization received expedited review and approval by Marc Lee, MD, Chair of the Banner Health 
Institutional Review Board (Phoenix Panel) on July 13, 2017 for conduction at Banner MD Anderson 
Cancer Center. This expedited review was performed in accordance with 21CFR56.110 (b) and/or 
45CFR46.110(b). This study has received approval for one year.  Federal regulations require all studies 
be reviewed at least annually. The final approved, stamped Informed Consent is available electronically. 
You must use copies of this Informed Consent exclusively. A copy of the signed Informed Consent 
document must be placed in the patient’s medical records. 
The Board’s approval to conduct your study will expire on July 12, 2018. The IRB requests that you 
submit a Continuing Review report one month prior to the June 19, 2018 IRB meeting. This allows time 
for processing and review prior to the IRB expiration date of the study. 
Any internal unanticipated problems or unexpected drug/biologic adverse events must be reported to the 
IRB within 7 working days of the investigator learning of the event. 
If you wish to change any aspect of this study, such as the procedures, the consent forms, or the 
investigators, please communicate your requested changes to the Board.  The new procedure is not to be 
initiated until the IRB approval has been given.   
Unusual events, results of the study or any additional information relative to the study must be submitted 
to the Board. A Closing report is required upon completion of the project.  In the event the study results 
are published, please send a copy to Banner Research so it may be included in the file. A copy of this 
letter will be retained electronically. 
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Rebecca Luiten 
Project # 14-17-0026 
iRIS Reference # 018409 
July 13, 2017 
Page Two 
The Board appreciates your participation in research. If you have any questions, please contact Jane 
Hoverson, CIP, CIM, CRC, Research Regulatory Specialist, at (480) 412-4083. 
Sincerely, 
Signature applied by Marc Lee  on 07/13/2017 04:22:12 PM MST 
Marc Lee, MD 
Chair, Banner Health IRB (Phoenix Panel) 
ML/jh 
cc: Research Director
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FWA #00002630 
IORG #0004299 
September 20, 2017 
Rebecca Luiten 
Attn: Alicja M Ball/Amelia Larsen 
Jasmine Neumann/Stephanie Henkel 
Banner MD Anderson Cancer Center  
2946 E. Banner Gateway Drive Ste.375 
Gilbert, AZ 85234 
RE: Project # 14-17-0026  Assessment of genetic terms list on patient satisfaction and anxiety 
level in an oncology genetic counseling clinic  
iRIS Reference # 018580 
IRB Review and Acknowledgement – Protocol Deviation 
 30 subjects consented with non-approved (unstamped) Informed Consent
Dear Dr. Luiten: 
This letter serves to notify you the Protocol Deviation for the above referenced study received 
review and acknowledgement by the Banner Health Institutional Review Board (Phoenix Panel) on 
September 19, 2017. No further action is required. This review was performed in accordance with 
45CFR46. 
A copy of this letter will be retained electronically. If you have any questions, please contact Jane 
Hoverson, CIP, CIM, CRC, Research Regulatory Specialist, at (480) 412-4083. 
Sincerely, 
Signature applied by Marc Lee  on 09/20/2017 09:20:25 PM MST 
Marc Lee, MD 
Chair, Banner Health IRB (Phoenix Panel) 
ML/jh 
cc: Research Director 
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